LEO Pharma Products in Australia

All LEO Pharma products in Australia must be prescribed or administered by a healthcare professional.

To view the Product Information (PI) or Consumer Medicine Information (CMI), click the underlined hyperlinks below the product names.

If you are visiting this site from New Zealand the relevant Data Sheet and Consumer Medicine Information for these products are available at www.medsafe.govt.nz

 Dermatology

  • Enstilar® Foam Spray – calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g foam spray (aerosol can)*
Dear Healthcare Professional, Enstilar® is now available with supply resumed.  LEO Pharma is actively notifying healthcare professionals to support appropriate patient access to Enstilar®. We sincerely apologise for any inconvenience that this may have caused you and your patients.
 
                      PI                 CMI

             *Enstilar® is not currently marketed in New Zealand

 

  •  Daivobet® 50/500 gel - calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g gel (bottle)

                   PI                  CMI   
         

  • Daivobet® 50/500 ointment - calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g ointment (tube) 

                   PI                 CMI            

 

  • Picato® gel - ingenol mebutate 0.015% and ingenol mebutate 0.05% gel (tube)        

                  PI                  CMI - Picato® gel 0.015%          CMI - Picato® gel 0.05%
        

  • Daivonex® cream - calcipotriol 50 microgram/g cream (tube)

Dear Healthcare Professional, Daivonex® Cream is currently experiencing a global shortage due to the lack of availability of one of the excipients in the formulation of the cream. LEO Pharma has submitted an application to the TGA for an alternative overseas calcipotriol only product to be available in Australia during the shortage period, and is awaiting the outcome. For further information about this shortage, please refer to the TGA's Medicines Shortage website: Calcipotriol - TGA Medicines Shortage listing  
   

                   PI               CMI  
    

  • Daivonex® scalp solution - calcipotriol 50 microgram/mL solution (bottle) - (Please note: this product was delisted from the PBS on 1st September 2012 and the product has been subsequently discontinued in Australia)


                   PI                 CMI          

          

 Medical device to be used by a trained healthcare professional

 

  •  Kleresca® - BioPhotonic treatment for Acne vulgaris - Kleresca.com.au*

               *Kleresca® is not available in New Zealand